{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:08:42Z","timestamp":1791223722551,"version":"4.1.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.autrev.2011.04.021","type":"journal-article","created":{"date-parts":[[2011,4,25]],"date-time":"2011-04-25T06:07:51Z","timestamp":1303711671000},"page":"599-608","source":"Crossref","is-referenced-by-count":146,"title":["An overview on the genetic of rheumatoid arthritis: A never-ending story"],"prefix":"10.1016","volume":"10","author":[{"given":"Carlo","family":"Perricone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2011.04.021_bb0005","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jbspin.2005.09.001","article-title":"Genetic basis of rheumatoid arthritis","volume":"72","author":"Dieud\u00e9","year":"2005","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2011.04.021_bb0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis","volume":"9","author":"Szodoray","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.021_bb0015","first-page":"179","article-title":"Susceptibility genes for rheumatoid arthritis \u2013 a rapidly expanding harvest","volume":"68","author":"Gregersen","year":"2010","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0020","first-page":"139","article-title":"Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries","volume":"65","author":"Greenberg","year":"2007","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0025","doi-asserted-by":"crossref","first-page":"J163","DOI":"10.1016\/j.jaut.2009.12.005","article-title":"Geo-epidemiology and autoimmunity","volume":"34","author":"Youinou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","article-title":"Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins","volume":"43","author":"MacGregor","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0035","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.04.021_bb0040","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1136\/ard.2007.076588","article-title":"Gene expression profiling in rheumatoid arthritis: current concepts and future directions","volume":"67","author":"Toonen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0045","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/BOR.0b013e328336474d","article-title":"Recent advances in the genetics of rheumatoid arthritis","volume":"22","author":"Raychaudhuri","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncprheum0020","article-title":"Cytokine networks\u2013towards new therapies for rheumatoid arthritis","volume":"1","author":"McInnes","year":"2005","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ejhg.2010.62","article-title":"Genome-wide gene and pathway analysis","volume":"18","author":"Luo","year":"2010","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0060","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.24749","article-title":"Shared familial aggregation of susceptibility to autoimmune diseases","volume":"60","author":"Hemminki","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0065","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1002\/art.1780210921","article-title":"HLA-D and Ia antigens in rheumatoid arthritis and systemic lupus erythematosus","volume":"21","author":"Stastny","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/sarh.2002.32552","article-title":"Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis","volume":"31","author":"Gonzalez-Gay","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2119\/2007-00123.Lee","article-title":"Several regions in the major histocompatibility complex confer risk for anti-CCP-antibody positive rheumatoid arthritis, independent of the DRB1 locus","volume":"14","author":"Lee","year":"2000","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2011.04.021_bb0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.24138","article-title":"Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci","volume":"60","author":"Vignal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0085","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/01.bor.0000209425.84775.23","article-title":"Genetic epidemiology of rheumatoid arthritis","volume":"18","author":"Oliver","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0095","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0100","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/art.21630","article-title":"A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity","volume":"54","author":"Gourraud","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0110","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1186\/ar2131","article-title":"A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for autoantibody production in rheumatoid arthritis","volume":"9","author":"Gourraud","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.04.021_bb0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/rheumatology\/kep338","article-title":"New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies","volume":"49","author":"Gyetvai","year":"2010","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0120","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.rdc.2010.03.002","article-title":"Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis","volume":"36","author":"Plenge","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2011.04.021_bb0125","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1093\/hmg\/ddp365","article-title":"Common and different genetic background for rheumatoid arthritis and coeliac disease","volume":"18","author":"Coenen","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0130","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/art.21049","article-title":"Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene","volume":"52","author":"Hinks","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.gene.6364159","article-title":"The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status","volume":"6","author":"Lee","year":"2005","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/art.20737","article-title":"Association of R602W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset\/disease severity effect","volume":"2","author":"Steer","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","article-title":"Role of PTPN22 in type 1 diabetes and other autoimmune diseases","volume":"18","author":"Bottini","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0150","first-page":"1984","article-title":"Association of PTPN22 with rheumatoid arthritis among South Asians in the UK","volume":"34","author":"Mastana","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/bies.10357","article-title":"PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease","volume":"25","author":"Vossenaar","year":"2003","journal-title":"Bioassay"},{"key":"10.1016\/j.autrev.2011.04.021_bb0165","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00296-009-0870-2","article-title":"The expression of PADI4 in synovium of rheumatoid arthritis","volume":"29","author":"Chang","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2011.04.021_bb0170","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/rheumatology\/kel023","article-title":"Association between PADI4 and rheumatoid arthritis: a meta-analysis","volume":"45","author":"Iwamoto","year":"2006","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/ard.2009.111294","article-title":"PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population","volume":"69","author":"Burr","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0180","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/rheumatology\/kei008","article-title":"PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population","volume":"44","author":"Martinez","year":"2005","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0185","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/498651","article-title":"Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4","volume":"77","author":"Plenge","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0190","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/archinte.168.15.1664","article-title":"Geographic variation in rheumatoid arthritis incidence among women in the United States","volume":"168","author":"Costenbader","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2011.04.021_bb0195","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/art.24759","article-title":"TRAF1 polymorphisms associated with rheumatoid arthritis susceptibility in Asians and in Caucasians","volume":"60","author":"Han","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0200","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.2008.106567","article-title":"The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases","volume":"69","author":"Kurreeman","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0205","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev.immunol.16.1.421","article-title":"Divergent roles for Fc receptors and complement in vivo","volume":"16","author":"Ravetch","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0210","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1128\/MCB.18.1.558","article-title":"4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB","volume":"18","author":"Arch","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0215","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.185.10.1777","article-title":"A regulatory role for TRAF1 in antigen-induced apoptosis of T cells","volume":"185","author":"Speiser","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2011.04.021_bb0220","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/art.23494","article-title":"Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population","volume":"58","author":"Kobayashi","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.0105-2896.2004.00211.x","article-title":"Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4","volume":"202","author":"Watford","year":"2004","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2011.04.021_bb0230","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/ard.2005.050385","article-title":"Changes in synovial tissue Jak-STAT expression in rheumatoid arthritis in response to successful DMARD treatment","volume":"65","author":"Walker","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0235","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2249.2006.03021.x","article-title":"Association of rheumatoid factor production with FcgammaRIIIa polymorphism in Taiwanese rheumatoid arthritis","volume":"144","author":"Chen","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature05329","article-title":"Global variation in copy number in the human genome","volume":"444","author":"Redon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2011.04.021_bb0245","doi-asserted-by":"crossref","first-page":"91-104","DOI":"10.1086\/510560","article-title":"A comprehensive analysis of common copy-number variations in the human genome","volume":"80","author":"Wong","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.166.1.531","article-title":"Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines","volume":"166","author":"Pricop","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0255","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1182\/blood.V90.3.1109","article-title":"Fc gammaRIIIa-158V\/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L\/R\/H phenotype","volume":"90","author":"Koene","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.04.021_bb0260","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1172\/JCI12952","article-title":"Cytokines and cellular interactions in inflammatory synovitis","volume":"107","author":"Arend","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.04.021_bb0265","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.3899\/jrheum.080186","article-title":"Associations between FCGR3A polymorphisms and susceptibility to rheumatoid arthritis: a metaanalysis","volume":"35","author":"Lee","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0270","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1136\/ard.2008.099309","article-title":"Contribution of Fcgamma receptor IIIA gene 158V\/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis","volume":"68","author":"Thabet","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0275","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","article-title":"Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin","volume":"280","author":"Fisher","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0280","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1073\/pnas.83.23.8819","article-title":"Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence","volume":"83","author":"Oldberg","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.04.021_bb0285","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/art.20808","article-title":"Two single-nucleotide polymorphisms in the 5\u2032 and 3\u2032 ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus","volume":"52","author":"D'Alfonso","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0290","first-page":"410","article-title":"Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism","volume":"32","author":"Xu","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0295","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/bbrc.2000.4146","article-title":"Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin","volume":"280","author":"Fisher","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0300","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.autrev.2011.04.021_bb0305","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2007-02-072850","article-title":"Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function","volume":"110","author":"Voskoboinik","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.04.021_bb0310","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2006-02-001412","article-title":"Variations of the perforin gene in patients with autoimmunity\/lymphoproliferation and defective Fas function","volume":"108","author":"Clementi","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2011.04.021_bb0315","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.0105-2896.2005.00249.x","article-title":"CTLA4 gene polymorphism and autoimmunity","volume":"204","author":"Gough","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2011.04.021_bb0320","article-title":"Abatacept treatment for rheumatoid arthritis","author":"Schiff","year":"2010","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0325","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/art.24503","article-title":"Confirmation of STAT4, IL2\/IL21, and CTLA4 polymorphisms in rheumatoid arthritis","volume":"60","author":"Daha","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0330","first-page":"2068","article-title":"Clinical usefulness of genetic information for predicting radiographic damage in rheumatoid arthritis","volume":"29","author":"Chen","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0335_1","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/art.21872","article-title":"Variation in radiologic joint destruction in rheumatoid arthritis differs between monozygotic and dizygotic twins and pairs of unrelated patients","volume":"54","author":"van der Helm-van Mil","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0335_2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/rheumatology\/keg190","article-title":"Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis","volume":"42","author":"Wagner","year":"2003","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0340","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/art.20989","article-title":"New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility","volume":"52","author":"du Montcel","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0345","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/art.21630","article-title":"A new classification of HLA-DRB1 alleles differentiates predisposing and protective alleles for rheumatoid arthritis structural severity","volume":"54","author":"Gourraud","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0350","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/ard.2007.075382","article-title":"Association between radiographic severity of rheumatoid arthritis and shared epitope alleles: differing mechanisms of susceptibility and protection","volume":"67","author":"Mewar","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0355","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0360","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1073\/pnas.94.7.3195","article-title":"Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation","volume":"94","author":"Wilson","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.04.021_bb0365","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/art.21750","article-title":"Association of tumor necrosis factor alpha polymorphism, but not the shared epitope, with increased radiographic progression in a seropositive rheumatoid arthritis inception cohort","volume":"54","author":"Khanna","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0370","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar2173","article-title":"Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoter","volume":"9","author":"Fonseca","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.04.021_bb0375","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P","article-title":"Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis","volume":"42","author":"Cantagrel","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0380","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2362.1992.tb01480.x","article-title":"A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro","volume":"22","author":"Pociot","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.autrev.2011.04.021_bb0385","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.gene.6363766","article-title":"IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels","volume":"2","author":"Buchs","year":"2001","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0390","first-page":"159","article-title":"IL1beta+3953 exon 5 and IL-2\u2013330 promoter polymorphisms in patients with rheumatoid arthritis","volume":"23","author":"Pawlik","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0395","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/art.10394","article-title":"Association of interleukin-4 and interleukin-1B gene variants with Larsen score progression in rheumatoid arthritis","volume":"47","author":"Genevay","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0400","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2011.04.021_bb0405","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/art.22814","article-title":"Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status","volume":"56","author":"Marinou","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0410","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/jc.2002-020092","article-title":"Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women","volume":"88","author":"Ferrari","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.autrev.2011.04.021_bb0415","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/08830189809084493","article-title":"Cytokines in autoimmune disorders","volume":"17","author":"Feldmann","year":"1998","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0420","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaci.2005.10.024","article-title":"IL-4\/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma","volume":"117","author":"Kabesch","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0425","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21832","article-title":"Association of the IL4R single-nucleotide polymorphism I50V with rapidly erosive rheumatoid arthritis","volume":"54","author":"Prots","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0430","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/ar2454","article-title":"Lack of association or interactions between the IL-4, IL-4Ralpha and IL-13 genes, and rheumatoid arthritis","volume":"10","author":"Marinou","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.04.021_bb0435","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0440","doi-asserted-by":"crossref","first-page":"9465","DOI":"10.1073\/pnas.95.16.9465","article-title":"Interleukin 10 secretion in relation to human IL-10 locus haplotypes","volume":"95","author":"Eskdale","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2011.04.021_bb0445","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/hmg\/ddh187","article-title":"Transcription of the IL10 gene reveals allele-specific regulation at the mRNA level","volume":"13","author":"Kurreeman","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0450","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","article-title":"Genetic control of the circulating concentration of transforming growth factor type beta1","volume":"8","author":"Grainger","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0455","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1136\/ard.62.9.907","article-title":"Transforming growth factor beta 1 gene (HSTGFB1) nucleotide T869C (codon 10) polymorphism is not associated with prevalence or severity of rheumatoid arthritis in a Caucasian population","volume":"62","author":"Pokorny","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0460","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.61.9.826","article-title":"Transforming growth factor beta1 gene polymorphism in rheumatoid arthritis","volume":"61","author":"Sugiura","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0465","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/ard.2004.031674","article-title":"Association of polymorphism in the transforming growth factor b1 gene with disease outcome and mortality in rheumatoid arthritis","volume":"64","author":"Mattey","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0470","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/art.10336","article-title":"Stromelysin 1 (matrix metalloproteinase 3) and HLA-DRB1 gene polymorphisms: association with severity and progression of rheumatoid arthritis in a prospective study","volume":"46","author":"Constantin","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.gene.6364050","article-title":"Association of matrix metalloproteinase 3 promoter genotype with disease outcome in rheumatoid arthritis","volume":"5","author":"Mattey","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.autrev.2011.04.021_bb0480","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1136\/ard.2006.067892","article-title":"Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study","volume":"66","author":"Lie","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0485","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/art.10119","article-title":"Variant mannose-binding lectin genotypes and outcome in early versus late rheumatoid arthritis: comment on the article by Ip et al","volume":"46","author":"Graudal","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0490","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.2007.071662","article-title":"Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study","volume":"67","author":"Karlson","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0495","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/BOR.0b013e3283383f87","article-title":"Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis","volume":"22","author":"Feely","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0500","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/art.1780361206","article-title":"Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha","volume":"36","author":"Elliott","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2011.04.021_bb0505","doi-asserted-by":"crossref","first-page":"ii94","DOI":"10.1136\/ard.62.suppl_2.ii94","article-title":"Rheumatoid arthritis in 2003: where are we now with treatment?","volume":"62","author":"Weinblatt","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2011.04.021_bb0510","first-page":"19","article-title":"The role of current strategies in the future treatment of rheumatoid arthritis","volume":"38","author":"Weinblatt","year":"1999","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0515","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2011.04.021_bb0520","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11926-007-0066-2","article-title":"Switching anti-TNF-alpha agents: what is the evidence?","volume":"9","author":"Erickson","year":"2007","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2011.04.021_bb0525","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1093\/hmg\/ddn245","article-title":"Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate, Barton A, Worthington J et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis","volume":"17","author":"Maxwell","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.autrev.2011.04.021_bb0530","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/art.11168","article-title":"Polymorphism at position \u2212308 of the tumor necrosis factor alpha gene influences outcome of infliximab therapy in rheumatoid arthritis","volume":"48","author":"Mugnier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0535","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/ard.62.6.526","article-title":"Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis","volume":"62","author":"Padyukov","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0540","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/03009740410005863","article-title":"Tumour necrosis factor-alpha (TNF-alpha) levels and influence of \u2212308 TNF-alpha promoter polymorphism on the responsiveness to infliximab in patients with rheumatoid arthritis","volume":"33","author":"Cuchacovich","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2011.04.021_bb0545","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/ard.2004.028167","article-title":"Polymorphism at position \u2212308 of the tumour necrosis factor alpha gene and rheumatoid arthritis pharmacogenetics","volume":"64","author":"Fonseca","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.04.021_bb0550","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/kel175","article-title":"The \u2212308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNFalpha-blockers in rheumatoid arthritis and spondyloarthritis patients","volume":"46","author":"Seitz","year":"2007","journal-title":"Rheumatology Oxford"},{"key":"10.1016\/j.autrev.2011.04.021_bb0555","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/art.23092","article-title":"Influence of \u2212308 A\/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritis","volume":"57","author":"Guis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0560","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/art.23430","article-title":"Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at \u2212308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor","volume":"58","author":"Marotte","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0565","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/tpj.2009.7","article-title":"TNF-alpha-308G\/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis","volume":"9","author":"O'Rielly","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.autrev.2011.04.021_bb0570","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1002\/art.21266","article-title":"Fcgamma receptor type IIIA polymorphisms influence treatment outcomes in patients with inflammatory arthritis treated with tumor necrosis factor alpha-blocking agents","volume":"52","author":"Tutuncu","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0575","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/art.22390","article-title":"Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis","volume":"56","author":"Kastbom","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.04.021_bb0580","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/ard.2009.118406","article-title":"Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment","volume":"69","author":"Tan","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T07:44:53Z","timestamp":1741160693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211000899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":117,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1568997211000899"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.04.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}